Regeneron Pharmaceuticals Inc (REGN)

Net profit margin

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net income	US$ in thousands	3,953,600	4,338,400	8,075,300	3,513,200	2,115,800
Revenue	US$ in thousands	13,044,200	12,113,500	16,014,400	8,440,200	7,833,200
Net profit margin		30.31%	35.81%	50.43%	41.62%	27.01%

December 31, 2023 calculation

Net profit margin = Net income ÷ Revenue
= $3,953,600K ÷ $13,044,200K
= 30.31%

Regeneron Pharmaceuticals, Inc.'s net profit margin has shown fluctuation over the past five years. In 2023, the net profit margin decreased to 30.14% from 35.64% in 2022. Despite this decrease, the company's net profit margin remains relatively healthy compared to previous years.

The peak performance in terms of net profit margin was recorded in 2021 at 50.25%, indicating the company's strong profitability during that period. The significant drop in 2022 followed by a slight decrease in 2023 suggests potential factors affecting the company's profitability, such as changes in expenses or revenue.

Overall, Regeneron Pharmaceuticals, Inc. has maintained a generally positive net profit margin trend over the five-year period, with occasional fluctuations. It is important for the company to closely monitor and manage its expenses and revenues to sustain and improve its net profit margin in the future.